Research at St Andrews

University > Research portal > Funded projects > Contribution by NRF2 upregulation to lung carcinogenesis, an...

Contribution by NRF2 upregulation to lung carcinogenesis, and the possible therapeutic value of NRF2 inhibition by GSK-3

Project: Standard

Participant(s)

Harrison, David James (PI)

Organisation(s)

School of Medicine

Details

Acronym	Contribution by NRF2 upregulation
Status	Finished
Effective start/end date	1/05/16 → 31/10/19
Funder Project Reference	MR/N009851/1
Funder	Medical Research Council
St Andrews funding	£108,141.83

Research outputs

Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacological activation of Nrf2 (NF-E2-related factor 2)
Research output: Contribution to journal › Article › peer-review
Experimental nonalcoholic steatohepatitis and liver fibrosis are ameliorated by pharmacological activation of Nrf2 (NF-E2-related factor 2)
Research output: Contribution to journal › Article › peer-review

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

ID: 249118263

Top